Article
Effects of single nucleotide polymorphisms of the folylpolyglutamate synthase gene on pemetrexed administration-induced nephropathy.
British journal of clinical pharmacology - 1 Dec 2023
Mitarai Yuki, Tanino Ryosuke, Nakashima Kazuhisa, Hotta Takamasa, Isobe Takeshi, Tsubata Yukari
Abstract excerpt
AIMS: Long-term administration of pemetrexed (PEM) in patients with lung cancer can cause renal damage, leading to treatment discontinuation. Previous reports have suggested that specific single nucleotide polymorphisms (SNPs) in the folylpolyglutamate synthase (FPGS) gene affect therapeutic efficacy; however, whether the FPGS SNPs affect renal function is unclear. Identifying SNPs related to renal damage during...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
